Immunocore Holdings plc

Direct answer

Immunocore Holdings plc is publicly traded on NASDAQ under the ticker IMCR.

Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for...

Can you invest in Immunocore Holdings plc?

Yes. Immunocore Holdings plc is publicly traded on NASDAQ under the ticker IMCR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Immunocore Holdings plc

Detailed equity research is provided by MarketSnap.